Chinook Therapeutics Inc 's

• KDNY's Stock Performance relative to its Competitors

Effector Therapeutics Inc Share Performance +300.00% Over The Past 5 Days

Effector Therapeutics Inc Profile Effector Therapeutics Inc is a biotech company focused on developing and commercializing effective cancer treatments. More about Effector Therapeutics Inc 's Market Share

Lumos Pharma Inc Share Performance -0.69% 30 Days

Lumos Pharma Inc Profile Lumos Pharma Inc is a biopharmaceutical company that focuses on developing therapeutics for rare diseases. Their business model revolves around identifying and repurposing existing drugs to create innovative treatments for patients with unmet medical needs in the rare disease space. More about Lumos Pharma Inc 's Market Share

Madrigal Pharmaceuticals Inc Share Performance +5.48% Over The Past 5 Days

Madrigal Pharmaceuticals Inc Profile Madrigal Pharmaceuticals Inc's business model is focused on developing and commercializing innovative therapeutic solutions for liver diseases, with a particular emphasis on non-alcoholic steatohepatitis (NASH) and other metabolic diseases. They aim to provide effective treatments to address unmet medical needs and improve patient outcomes in these areas. More about Madrigal Pharmaceuticals Inc 's Market Share

Mira Pharmaceuticals Inc Share Performance -2.26% Over The Past 5 Days

Mira Pharmaceuticals Inc Profile Mira Pharmaceuticals Inc's business model is focused on the development and sale of pharmaceutical products, with a particular emphasis on research and innovation in the healthcare industry. More about Mira Pharmaceuticals Inc 's Market Share

Milestone Pharmaceuticals Inc Share Performance -36.96% One Year

Milestone Pharmaceuticals Inc Profile Milestone Pharmaceuticals Inc. is a pharmaceutical company that focuses on developing and commercializing innovative therapies for cardiovascular diseases. Their business model revolves around identifying unmet medical needs in the cardiovascular space and leveraging their expertise in drug development to create novel treatments. By conducting rigorous research, clinical trials, and collaborations, Milestone Pharmaceuticals aims to bring effective and safe medications to market, positively impacting patients' lives. More about Milestone Pharmaceuticals Inc 's Market Share

Sources: Chinook Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, August 31, 2026 4:59 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Chinook Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.